398 related articles for article (PubMed ID: 20462660)
1. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
2. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
Ajayi AA; Kolawole BA; Udoh SJ
Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
Tamdee D; Charuluxananan S; Punjasawadwong Y; Tawichasri C; Patumanond J; Sriprajittichai P
Anesth Analg; 2009 Nov; 109(5):1606-11. PubMed ID: 19843798
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
Metze D; Reimann S; Beissert S; Luger T
J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
[TBL] [Abstract][Full Text] [Related]
9. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone: a case report of pruritus from an antipruritic.
Sullivan JR; Watson A
Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
[TBL] [Abstract][Full Text] [Related]
12. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced pruritus: an update.
Reich A; Szepietowski JC
Clin Exp Dermatol; 2010 Jan; 35(1):2-6. PubMed ID: 19663845
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone for the management of post-burn pruritus: A preliminary report.
LaSalle L; Rachelska G; Nedelec B
Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients.
Siepmann D; Weishaupt C; Luger TA; Ständer S
Dermatology; 2011; 223(4):374-80. PubMed ID: 22301826
[TBL] [Abstract][Full Text] [Related]
16. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
Chang Y; Golkar L
Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous naloxone for the prevention of intrathecal morphine induced pruritus in elective Caesarean delivery.
Lockington PF; Fa'aea P
Anaesthesia; 2007 Jul; 62(7):672-6. PubMed ID: 17567342
[TBL] [Abstract][Full Text] [Related]
18. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
[TBL] [Abstract][Full Text] [Related]
19. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
Brune A; Metze D; Luger TA; Ständer S
Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
[TBL] [Abstract][Full Text] [Related]
20. Relieving the pruritus of atopic dermatitis: a meta-analysis.
Sher LG; Chang J; Patel IB; Balkrishnan R; Fleischer AB
Acta Derm Venereol; 2012 Sep; 92(5):455-61. PubMed ID: 22773026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
